Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (249)

81

Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer : OlympiAD

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Hodgson, D. | Lai, Z. | Dearden, S. | +9

CommentIn: Ann Oncol. 2021 Dec;32(12):1460-1462. - PMID 34678412

82

Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers

enthalten in: Seminars in cancer biology | 2021

von Le Page, C. | Amuzu, S. | Rahimi, K. | +3

83

BRCA Mutations in Prostate Cancer : Assessment, Implications and Treatment Considerations

enthalten in: International journal of molecular sciences | 2021

von Shah, S. | Rachmat, R. | Enyioma, S. | +3

84

Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps

enthalten in: Molecular cell | 2021

von Paes Dias, M. | Tripathi, V. | van der Heijden, I. | +18

85

Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants

enthalten in: Cancer treatment reviews | 2021

von Macchini, M. | Centonze, F. | Peretti, U. | +5

86

Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations

enthalten in: Breast cancer research and treatment | 2021

von Xu, J. | Keenan, T. | Overmoyer, B. | +10

87

Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries : Exploratory Subgroup Analysis of the Phase III EMBRACA Trial

enthalten in: Cancer research and treatment | 2021

von Lee, K. | Sohn, J. | Goodwin, A. | +4

88

Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers

enthalten in: Investigational new drugs | 2021

von Li, M. | Meng, T. | Song, S. | +9

89

The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells

enthalten in: Genes & development | 2021

von Simoneau, A. | Xiong, R. | Zou, L.

90

BRCA gene testing in women with high-grade serous ovarian carcinoma

enthalten in: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology | 2021

von Kansu, B. | Gardner, J. | Price-Tate, R. | +2